Source link : https://www.newshealth.biz/health-news/study-tests-btk-inhibitor-for-poorly-controlled-asthma/
The investigational Bruton’s tyrosine kinase (BTK) inhibitor rilzabrutinib was associated with numerical decreases in loss of asthma control events for patients with poorly controlled asthma, according to a randomized phase II trial reported at the recent American Thoracic Society annual meeting. In this exclusive MedPage Today video, Leda Mannent, MD, global project head of immunology […]
Author : News Health
Publish date : 2024-06-20 15:56:03
Copyright for syndicated content belongs to the linked Source.
in Health